Filed Mar 9, 2026Period of report Mar 5, 20260001178913-26-000787
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseMar 5, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF1
10,000
$1.23
$12.30K
188,098
Direct
Filing footnotes · 1
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.2287 to $1.245 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Feb 11, 2026Period of report Feb 10, 20260001178913-26-000414
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseFeb 10, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF1
7,500
$1.48
$11.10K
—
Direct
Filing footnotes · 1
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.4799 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Filed Feb 11, 2026Period of report Feb 9, 20260001178913-26-000411
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseFeb 9, 2026
Ordinary Shares, par value NIS 0.0000769 per shareF1
18,000
$1.24
$22.32K
178,098
Direct
Filing footnotes · 1
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.299 inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Miranda Jayne ToledanoDirector · Chief Executive Officer
4
Filed Dec 30, 2025Period of report Dec 29, 20250001178913-25-004125
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
PurchaseDec 29, 2025
Ordinary Shares, par value NIS 0.0000769 per shareF1
11,000
$1.8102
$19.91K
426,575
Direct
Filing footnotes · 1
F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $1.82, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.